Rolf Gedeborg

3.5k total citations
92 papers, 2.5k citations indexed

About

Rolf Gedeborg is a scholar working on Emergency Medicine, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Rolf Gedeborg has authored 92 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Emergency Medicine, 18 papers in Pulmonary and Respiratory Medicine and 14 papers in Epidemiology. Recurrent topics in Rolf Gedeborg's work include Cardiac Arrest and Resuscitation (16 papers), Prostate Cancer Treatment and Research (14 papers) and Trauma and Emergency Care Studies (12 papers). Rolf Gedeborg is often cited by papers focused on Cardiac Arrest and Resuscitation (16 papers), Prostate Cancer Treatment and Research (14 papers) and Trauma and Emergency Care Studies (12 papers). Rolf Gedeborg collaborates with scholars based in Sweden, United Kingdom and United States. Rolf Gedeborg's co-authors include Karl Michaëlsson, Håkan Melhus, Lars Berglund, Liisa Byberg, Alicja Wolk, Greta Snellman, Johan Sundström, L. Byberg, Sten Rubertsson and Hans Garmo and has published in prestigious journals such as The Lancet, PLoS ONE and American Journal of Clinical Nutrition.

In The Last Decade

Rolf Gedeborg

89 papers receiving 2.4k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Rolf Gedeborg 653 506 487 474 354 92 2.5k
Theresa O’Connor 291 0.4× 353 0.7× 253 0.5× 217 0.5× 173 0.5× 60 4.3k
Murray Tilyard 282 0.4× 79 0.2× 500 1.0× 384 0.8× 458 1.3× 77 2.5k
Khurram Nasir 143 0.2× 371 0.7× 293 0.6× 340 0.7× 569 1.6× 140 3.9k
Bjørn Olav Åsvold 303 0.5× 100 0.2× 95 0.2× 542 1.1× 327 0.9× 188 5.0k
Bo Freyschuss 220 0.3× 73 0.1× 211 0.4× 280 0.6× 323 0.9× 27 2.7k
Xuemei Luo 520 0.8× 213 0.4× 111 0.2× 259 0.5× 238 0.7× 112 3.3k
Alanna A. Morris 281 0.4× 249 0.5× 67 0.1× 301 0.6× 219 0.6× 147 3.2k
Ludger Pientka 123 0.2× 135 0.3× 266 0.5× 314 0.7× 320 0.9× 93 2.4k
Rehan Qayyum 241 0.4× 97 0.2× 86 0.2× 403 0.9× 157 0.4× 105 2.1k
Lisa Langsetmo 425 0.7× 67 0.1× 1.7k 3.5× 399 0.8× 1.0k 2.9× 124 3.6k

Countries citing papers authored by Rolf Gedeborg

Since Specialization
Citations

This map shows the geographic impact of Rolf Gedeborg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rolf Gedeborg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rolf Gedeborg more than expected).

Fields of papers citing papers by Rolf Gedeborg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rolf Gedeborg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rolf Gedeborg. The network helps show where Rolf Gedeborg may publish in the future.

Co-authorship network of co-authors of Rolf Gedeborg

This figure shows the co-authorship network connecting the top 25 collaborators of Rolf Gedeborg. A scholar is included among the top collaborators of Rolf Gedeborg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rolf Gedeborg. Rolf Gedeborg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Westerberg, Marcus, Hans Garmo, Jonas F. Ludvigsson, P. Stattin, & Rolf Gedeborg. (2025). Discriminative Ability of the Charlson Comorbidity Index for Long-Term Mortality in a General Population: Nationwide, Population-Based Study of 10 Million Adults in Sweden. Clinical Epidemiology. Volume 17. 983–993.
2.
Corsini, Christian, et al.. (2025). Functional outcomes after primary vs delayed robot-assisted radical prostatectomy following active surveillance. JNCI Cancer Spectrum. 9(2). 1 indexed citations
3.
Westerberg, Marcus, Lennart Holm, Hans Garmo, P. Stattin, & Rolf Gedeborg. (2025). Cohort Profile Update: The National Prostate Cancer Register of Sweden and PCBase. International Journal of Epidemiology. 54(6).
4.
Garmo, Hans, et al.. (2025). Improved adherence to prostate cancer guidelines concomitant with public reporting. Nationwide population-based study. Scandinavian Journal of Urology. 60. 50–58. 1 indexed citations
5.
Garmo, Hans, et al.. (2025). Incidence and prognostic implications of prostate-specific antigen persistence and relapse after radical prostatectomy: population-based study. JNCI Journal of the National Cancer Institute. 117(6). 1142–1150. 2 indexed citations
6.
Garmo, Hans, Kerri Beckmann, Ola Bratt, et al.. (2025). Prostate cancer characteristics in fathers and risk of early onset high‐risk prostate cancer in sons. International Journal of Cancer. 158(4). 977–983. 1 indexed citations
7.
Westerberg, Marcus, et al.. (2024). Assessment of variability in life expectancy in older men by use of new comorbidity indices. A nationwide population-based study. Scandinavian Journal of Urology. 59. 207–209. 5 indexed citations
8.
Svennblad, Bodil, et al.. (2024). The long-term conditional mortality rate in older ICU patients compared to the general population. Critical Care. 28(1). 368–368. 2 indexed citations
9.
Corsini, Christian, et al.. (2023). Survival Trend in Individuals With De Novo Metastatic Prostate Cancer After the Introduction of Doublet Therapy. JAMA Network Open. 6(10). e2336604–e2336604. 17 indexed citations
10.
11.
George, Gincy, Hans Garmo, Jan Adolfsson, et al.. (2023). Use of Antiepileptic Drugs and Risk of Prostate Cancer: A Nationwide Case-Control Study in Prostate Cancer Data Base Sweden. Journal of Oncology. 2023. 1–7. 1 indexed citations
12.
Gedeborg, Rolf, Fredrik Sandin, Camilla Thellenberg‐Karlsson, et al.. (2023). Uptake of doublet therapy for de novo metastatic castration sensitive prostate cancer: a population-based drug utilisation study in Sweden. Scandinavian Journal of Urology. 58. 1 indexed citations
13.
Gedeborg, Rolf, Margaret Warner, Lihui Chen, et al.. (2014). Internationally comparable diagnosis-specific survival probabilities for calculation of the ICD-10–based Injury Severity Score. The Journal of Trauma: Injury, Infection, and Critical Care. 76(2). 358–365. 52 indexed citations
14.
15.
Byberg, Liisa, Rolf Gedeborg, Thomas Cars, et al.. (2011). Prediction of fracture risk in men: A cohort study. Journal of Bone and Mineral Research. 27(4). 797–807. 27 indexed citations
16.
Snellman, Greta, Håkan Melhus, Rolf Gedeborg, et al.. (2010). Correction: Determining Vitamin D Status: A Comparison between Commercially Available Assays. PLoS ONE. 5(9). 19 indexed citations
17.
Michaëlsson, Karl, John A. Baron, Greta Snellman, et al.. (2010). Plasma vitamin D and mortality in older men: a community-based prospective cohort study. American Journal of Clinical Nutrition. 92(4). 841–848. 202 indexed citations
18.
Gedeborg, Rolf, Henrik Engquist, Lars Berglund, & Karl Michaëlsson. (2008). Identification of Incident Injuries in Hospital Discharge Registers. Epidemiology. 19(5). 860–867. 54 indexed citations
19.
Johansson, Jakob, Rolf Gedeborg, & Sten Rubertsson. (2004). Vasopressin versus continuous adrenaline during experimental cardiopulmonary resuscitation. Resuscitation. 62(1). 61–69. 20 indexed citations
20.
Gedeborg, Rolf, Hans C son Silander, Elisabeth Ronne-Engström, Sten Rubertsson, & Lars Wiklund. (1997). Effects of "high dose" epinephrine on cerebral blood flow during experimental open chest cardiopulmonary resuscitation.. Critical Care Medicine. 25. 32. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Theresa O’Connor Breakdown of academic impact, for papers by Murray Tilyard Breakdown of academic impact, for papers by Khurram Nasir Breakdown of academic impact, for papers by Bjørn Olav Åsvold Breakdown of academic impact, for papers by Bo Freyschuss Breakdown of academic impact, for papers by Xuemei Luo Breakdown of academic impact, for papers by Alanna A. Morris Breakdown of academic impact, for papers by Ludger Pientka Breakdown of academic impact, for papers by Rehan Qayyum Breakdown of academic impact, for papers by Lisa Langsetmo
Rankless by CCL
2026